T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$1.68B |
| 2 |
Eli Lilly
LLY
|
+$1.43B |
| 3 |
Bank of America
BAC
|
+$1.17B |
| 4 |
Tesla
TSLA
|
+$1.13B |
| 5 |
Wells Fargo
WFC
|
+$734M |
Top Sells
| 1 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$20.6B |
| 2 |
Microsoft
MSFT
|
+$5.74B |
| 3 |
Amazon
AMZN
|
+$3.33B |
| 4 |
Yum! Brands
YUM
|
+$2.6B |
| 5 |
Salesforce
CRM
|
+$2.35B |
Sector Composition
| 1 | Technology | 26.11% |
| 2 | Healthcare | 18.73% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.33% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
951
Asbury Automotive
ABG
$4.97B
| $16.7M | ﹤0.01% |
110,675
-14,666
| -12% | -$2.22M |
|
952
Akamai
AKAM
$11.4B
| $16.7M | ﹤0.01% |
207,984
-1,135,547
| -85% | -$91.2M |
|
953
NCR Voyix
VYX
$1.8B
| $16.7M | ﹤0.01% |
1,429,446
-517,001
| -27% | -$6.03M |
|
954
Hormel Foods
HRL
$14B
| $16.7M | ﹤0.01% |
366,758
-2,296
| -0.6% | -$104K |
|
955
Home BancShares
HOMB
$5.79B
| $16.6M | ﹤0.01% |
738,494
-9,941,200
| -93% | -$224M |
|
|
MODV
956
DELISTED
ModivCare
MODV
| $16.6M | ﹤0.01% |
166,770
-641,271
| -79% | -$63.9M |
|
|
CCXI
957
DELISTED
ChemoCentryx, Inc.
CCXI
| $16.6M | ﹤0.01% |
320,461
+10,332
| +3% | +$534K |
|
958
Nordson
NDSN
$12.8B
| $16.5M | ﹤0.01% |
77,942
+5,980
| +8% | +$1.27M |
|
959
Alector
ALEC
$290M
| $16.5M | ﹤0.01% |
1,743,391
-104,734
| -6% | -$991K |
|
960
Federal Signal
FSS
$7.77B
| $16.4M | ﹤0.01% |
439,742
-2,359,655
| -84% | -$88.1M |
|
961
Constellium
CSTM
$2.09B
| $16.4M | ﹤0.01% |
1,614,729
-14,317,895
| -90% | -$145M |
|
|
ITCI
962
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $16.3M | ﹤0.01% |
350,956
+310,214
| +761% | +$14.4M |
|
963
Duolingo
DUOL
$14.2B
| $16.3M | ﹤0.01% |
170,788
-955,377
| -85% | -$91M |
|
964
Ambev
ABEV
$35.7B
| $16.2M | ﹤0.01% |
5,728,800
+66,600
| +1% | +$188K |
|
965
Mercury Systems
MRCY
$4.38B
| $16.2M | ﹤0.01% |
398,954
+19,820
| +5% | +$805K |
|
966
Victoria's Secret
VSCO
$2.17B
| $16.2M | ﹤0.01% |
554,855
+1,013
| +0.2% | +$29.5K |
|
967
Evertec
EVTC
$2.19B
| $16.1M | ﹤0.01% |
512,254
+4,441
| +0.9% | +$139K |
|
968
UDR
UDR
$12.9B
| $16M | ﹤0.01% |
382,800
-2,271
| -0.6% | -$94.7K |
|
969
Garmin
GRMN
$46.4B
| $15.9M | ﹤0.01% |
198,108
+1,119
| +0.6% | +$89.9K |
|
970
Teradata
TDC
$2.04B
| $15.8M | ﹤0.01% |
508,800
-361,094
| -42% | -$11.2M |
|
971
Healthpeak Properties
DOC
$12.6B
| $15.8M | ﹤0.01% |
689,228
-6,554
| -0.9% | -$150K |
|
972
Service Corp International
SCI
$11.3B
| $15.7M | ﹤0.01% |
272,732
-23,488
| -8% | -$1.36M |
|
973
LCI Industries
LCII
$2.52B
| $15.7M | ﹤0.01% |
154,587
-521,105
| -77% | -$52.9M |
|
974
Wayfair
W
$11.7B
| $15.5M | ﹤0.01% |
477,037
+4,812
| +1% | +$157K |
|
975
FTI Consulting
FCN
$5.4B
| $15.5M | ﹤0.01% |
93,358
-328,448
| -78% | -$54.4M |
|